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Understanding Pathophysiology and its 
Significance   
 
Shailendra Jain RN, BA, MS 
Introduction References Contd.. 
According to National kidney Foundation (NHF) patients with AS 
symptoms may include: blood in the urine (hematuria), protein in the 
urine (proteinuria), and high blood pressure (hypertension). It causes 
damage to the kidney through scar formation in the glomerular basement 
membrane (GBM) of a normal kidney structures. Studies published by 
NHF also shows that 80% of boys with X-linked Alport syndrome 
develops hearing loss at some point in their lives. Both gender with 
autosomal recessive AS typically have childhood hearing loss and their 
parents develop hearing loss at a later stage. Finally studies published by 
NHF shows that, people with AS also have slow decline of vision, which 
may lead to cataract formation and corneal erosion if left untreated. Some 
people with this disease have abnormal pigment of the retina called dot-
and-fleck retinopathy. Alport syndrome may also results in the swelling of 
legs, ankle, feet, and around the eyes (Iijima, Nozu, Kamei, Nakayama, Ito, 
Matsuoka & Matsuo, 2010).  
Alport syndrome is rare genetic disorder of the glomerulus in the kidneys that can 
be X-linked, Autosomal recessive, or Autosomal dominant in nature.  Clinical 
manifestation includes hearing loss, hematuria, proteinuria, and hypertension 
(Cheungpasitporn, Kaewpoowat, Suksaranjit, Kittanamongkolchai, Srivali, 
Ungprasert, & Rangan, 2012).  It is most common disease in males. A 24-hour 
urine specimen is usually obtained to check for proteinuria and elevated 
creatinine, which indicate acute renal failure (Cosgrove, 2012).  A renal biopsy 
and ultrasounds is used to confirm the diagnosis of Alport Syndrome. Patients 
that are diagnosed with such disease require dialysis and referral to an 
ophthalmology and audiology.  The following poster will help in understanding 
the signs and symptoms, pathophysiology, and nursing implication of Alport 
syndrome based on information found in literature research.  
 Otterbein University, Westerville, Ohio  
  
Signs and Symptoms 
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                Literary Research on Alport syndrome  
 The pathophysiology of AS is complex in nature. According to the information obtain 
from Alport Syndrome Foundation website, the syndrome is caused by genetic 
mutations that affect the glomeruli which are the microfiltration units inside the 
kidney. The glomeruli contain GBM that allows filtration of blood through the 
membrane. The normal structures of the GMB are replaced by scar tissue, leading to 
failure in the filtration system causing kidney failure in the AS. Type IV collagen is a 
major part of important tissue structures called basement membranes that are present 
in the kidneys. These proteins spread and result in GBM thickening and impairment of 
selectivity with subsequent glomerular sclerosis, interstitial fibrosis, and renal failure. 
Type IV collagen comes from a family of six proteins know as alpha-1 through alpha-6. 
Mutation in alpha-3, alpha4, and alpha-5 chains cause Alport syndrome.  X-linked AS is 
the most common form that accounts for 80% to 85% of the cases and results from 
mutations of the alpha-5 chain type IV collagen found inside gene COL4A5 (Rheault, 
2012). Autosomal Recessive AS accounts for 10% to 15% of the cases and is caused by 
mutation in the alpha-3 or alpha 4 chains found in COL4A3 or COL4A4 genes. Finally, 
the rare cases of autosomal dominant AS is due to heterozygous transformation in 
COL4A3 or COL4A4 also occur in 5% of cases (Bassareo. Marras, & Mercuro, 2010).  
The above image obtained from Medscape website shows the 
electron micrograph of a kidney biopsy from a patient with Alport syndrome. 
Note the scar tissue formation in the glomerular basement membrane (see 
arrows). 
Implication for Nursing Care 
Nurses play an important role in secondary and tertiary prevention against AS. Institute for 
Work and Health states that the goal of secondary prevention is to slow the progress of disease in its earliest 
stages (2014). Nurses need to continue encourage patients with the family history of AS to have regular exams 
and screening tests to prevent complication from such disease. They educate patient about the importance of 
blood pressure management to prevent further complication. They educate patient about diet, limiting fluids, 
and other treatments options.  They perform counseling and education to increase coping skills among patient 
with such disease. At dialysis center, nurses assist physician in performing hemodialysis and peritoneal 
dialysis on patient with renal failure secondary to AS. Nurses also can help patients in learning new skills such 
as lip reading or sign language and getting hearing aids. They teach younger men with Alport syndrome the 
importance of using hearing protection in noisy environments.  
Finally, the goal of tertiary prevention is to prevent further physical deterioration and maximize 
quality of life (Institute for Work and Health, 2014). It focuses on helping people manage complicated health 
problem such as hearing loss, blindness, and kidney failure secondary to AS. Nurses assist patients with AS by 
providing information about support groups such as Alport Syndrome Foundation and National Organization 
for Rear Disorders. They also provide education about lifestyle modifications including diet, medication 
administration and other preventive measure for patients undergoing kidney transplant secondary to end 
stage kidney failure. Some trained nurses also provide genetic counseling to the patient with AS because the 
disorder is inherited. They also AS patient with rehabilitation program and setting up patient support groups. 
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Conclusion 
The content of this poster helped in identifying the common signs and symptoms of AS, pathophysiology, and 
its implication to nursing care. The disease is more common among man and can be diagnosed as early at 2 
years old. This genetic disorder not only affects the kidney, but also their vision, and hearing leading to end 
stage renal failure, hearing loss, and blindness. It is important to provide patients with AS secondary and 
tertiary prevention methods to manage complications from such genetic disorder. Through early screening 
using genetic test can help in detecting this disease and can protect these patient from developing complication 
and injury. The evaluation can also be made using blood test, urine test, ultrasound, and kidney biopsy 
(Kashtan, Ding, Gregory, Gross, Heidet, Knebelmann, & Licht, 2013).   
 
            There is no specific treatment available against AS. People with such disease are treated symptomatically. 
Kidney transplantation has showed some success in-patient with end-sate kidney failure. Medical researchers 
are constantly working hard on understanding why people develop such disease and its treatments. Several 
laboratory tests are being conducted on animals with AS to find the best treatment. (Temme, Kramer, Jager, 
Lange, Peters, Müller, &  Gross, 2012).  Overall the joint effort among nurses and other healthcare providers can 
help patient with AS to manage their disease. 
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